-
CLAIMS-BASED LIPID-LOWERING THERAPY COVERAGE COMPARED TO CONVENTIONAL DRUG-SPECIFIC MEDICATION ADHERENCE AND PERSISTENCE METRICS
Aug 11, 2026, 17:15 PM -
SOCIO-ECONOMIC BURDEN OF ADHD: GLOBAL INSIGHTS AND PRELIMINARY FINDINGS FROM HONG KONG
Aug 11, 2026, 17:15 PM -
GENERATIVE AI-ASSISTED REVIEW OF COST-EFFECTIVENESS EVIDENCE TO INFORM HEALTH TECHNOLOGY ASSESSMENT STRATEGY
Aug 11, 2026, 17:15 PM -
COST-EFFECTIVENESS ANALYSIS OF ADJUVANTED RSVPREF3 OA VACCINE IN ADULTS AGED =75 YEARS AND THE COMORBID POPULATION AGED 60-74 YEARS IN SWITZERLAND
Aug 11, 2026, 17:15 PM -
HEALTH IMPACT AND COST-EFFECTIVENESS OF DIGITAL MESSAGING NUDGES ON INFLUENZA VACCINE UPTAKE AMONG CHINESE OLDER ADULTS: A REAL-WORLD TRIAL
Aug 11, 2026, 17:15 PM -
SOLAR: AN OBSERVATIONAL STUDY OF THE LONG-TERM EFFECTIVENESS OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR IN PEOPLE WITH CYSTIC FIBROSIS USING DATA FROM THE FRENCH CYSTIC FIBROSIS REGISTRY—IMPACT ON QUALITY OF LIFE AND HEALTH UTILITY VALUES
Aug 11, 2026, 17:15 PM -
FINANCIAL IMPACT OF BUNDLED CONTRACTS IN HEMODIALYSIS: A TOTAL COST OF OWNERSHIP (TCO) CASE STUDY OF A REGION IN SWEDEN
Aug 11, 2026, 17:15 PM -
CHARACTERIZING FGFR BIOMARKER TESTING IN METASTATIC UROTHELIAL CARCINOMA THROUGH NORSTELLALINQ LINKED CLAIMS AND ELECTRONIC HEALTH RECORDS, INCLUDING CLINICAL NOTES WITH HUMAN-IN-THE-LOOP LLM EXTRACTION
Aug 11, 2026, 17:15 PM -
CAPTURING THE DOWNSIDE: A TARGETED REVIEW OF ADVERSE EVENT COSTS AND DISUTILITY VALUES IN NICE APPRAISALS
Aug 11, 2026, 17:15 PM -
IMPACT OF CORRECTING INCOMPLETE VACCINATION RECORDS FOR IN-MIGRANTS ON LOW-COVERAGE AREA IDENTIFICATION FOR PEDIATRIC PNEUMOCOCCAL CONJUGATE VACCINATION IN A MUNICIPALITY: THE VENUS STUDY
Aug 11, 2026, 17:15 PM -
A LOCAL-FIRST, PRIVACY-PRESERVING PLATFORM INTEGRATING THE FULL SYSTEMATIC REVIEW AND META-ANALYSIS PIPELINE WITH ON-DEVICE AI
Aug 11, 2026, 17:15 PM -
TRENDS IN PRESCRIBING OF HORMONE REPLACEMENT THERAPY IN ELIGIBLE WOMEN AGED 40+ USING US REAL-WORLD DATA: 2017-2025
Aug 11, 2026, 17:15 PM -
BIOMARKERS ASSOCIATED WITH RISK OF SYSTEMIC COMPLICATIONS IN SJOGREN'S DISEASE: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:15 PM -
THE BIOSECURE EFFECT: EU MARKET ACCESS IMPLICATIONS FOR CHINA-ORIGINATED PD-(L)1 INHIBITORS
Aug 11, 2026, 17:15 PM -
OUTCOMES-BASED AGREEMENT ARCHITECTURE FOR CELL AND GENE THERAPIES: TRANSLATING EU5 STAGED PAYMENT MODELS FOR CMS IMPLEMENTATION
Aug 11, 2026, 17:15 PM -
THE DUTCH STEPWISE WILLINGNESS-TO-PAY THRESHOLDS: INCREASING CHALLENGES FOR ACCESS TO NEXT-GENERATION DRUG INNOVATIONS
Aug 11, 2026, 17:15 PM -
FEASIBILITY OF IDENTIFYING GENOTYPE-DEFINED DUCHENNE MUSCULAR DYSTROPHY POPULATIONS USING HUMAN-IN-THE-LOOP LLM AND LINKED CLINICAL NOTES FROM NORSTELLALINQ EHR
Aug 11, 2026, 17:15 PM -
TELEMEDICINE COST SAVINGS ARE CONDITIONAL RATHER THAN AUTOMATIC: A SYSTEMATIC REVIEW OF ECONOMIC EVIDENCE AND ITS IMPLICATIONS FOR REMOTE AND UNDERSERVED HEALTH SYSTEMS
Aug 11, 2026, 17:15 PM -
DEVELOPMENT OF A NEW COST-EFFECTIVENESS MODEL FOR CHRONIC HEPATITIS B VIRUS INFECTION BASED ON THE B-WELL TRIAL: VALIDATION OF HYBRID COHORT MODEL APPROACH
Aug 11, 2026, 17:15 PM -
THE ECONOMIC AND HUMANISTIC BURDEN OF PULMONARY ARTERIAL HYPERTENSION IN UAE
Aug 11, 2026, 17:15 PM
